Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
NVDA -0.4EWJ 0.37TECK.B.TO -2.09CNQ.TO 0.71HHL.TO 0.075SYLD 0.03HAC.TO 0.04TRU -0.01
EssilorLuxottica (ESLOY)

OTCMKTS:ESLOY

EssilorLuxottica (ESLOY)

101.92
-0.00 (0.00%)
as of Jun 18, 2026, 12:00:00 am Market Open.
14 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0
TOP PICK

EssilorLuxottica(ESLOY)

Dec 28, 2023

Lenses plus frames. Has a lock on the whole value chain. Purchase of Grant Vision will dramatically change its business over the next several years. Use of lenses has increased because of aging demographics plus faster eye deterioration from computer screens. Also a fashion statement. Great technology. Yield is 1.7%.

(Analysts’ price target is $109.40)
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
Track your Stocks in your Watch List
PAST TOP PICK

EssilorLuxottica(ESLOY)

Jun 15, 2023
(A Top Pick Jun 29/22, Up 23%)

Great growth from a demographic point of view. Largest player in the world in this area. Almost like an oligopoly, especially in making lenses. Really good lens technology, very innovative. Great story. Buy here and still do well.

Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$91.14

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
PAST TOP PICK

EssilorLuxottica(ESLOY)

Oct 17, 2022
(A Top Pick Sep 30/21, Down 19%) A global leader in design, manufacturing and distribution of eyeglasses as well as frames and has a high market share. Eye wear has an attractive long term growth profile. It is clear where management is heading.
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$74.97

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
PAST TOP PICK

EssilorLuxottica(ESLOY)

Aug 29, 2022
(A Top Pick Aug 24/21, Down 19%) It is a leader in the design, manufacturing and distribution of lenses, frames and sunglasses. Has a great balance sheet and should have good growth for the next few years. It acquired Grand Vision, mostly European, which changed the dynamics of the company and helps them to have a broader digital component. Has a 2.3% dividend.
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$75.18

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
PAST TOP PICK

EssilorLuxottica(ESLOY)

Jul 25, 2022
(A Top Pick Jul 22/21, Down 11%) Whole spectrum of eyewear business. Screen time has increased demand for kids' eyewear. Demographic play for older adults. Balance sheet getting better. Designer brands. Corporate governance improved.
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$78.83

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
TOP PICK

EssilorLuxottica(ESLOY)

Jun 29, 2022
price target N/A The global leader in optical frames, lens and sunglasses. The eyewear business is long-term resilient and will grow. A great demographic play, too. Over the last two years, screen use has soared and has caused a lot of eye problems. They bought Grand Vision, which is transformational in a digital way. Pays a 2.3X dividend. Strong balance sheet and cash flow growth will rise.
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$74.93

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
PAST TOP PICK

EssilorLuxottica(ESLOY)

Jan 14, 2022
(A Top Pick May 07/21, Up 14%) Believes company is in process of optimization previous mergers. Covid-19 pandemic has had adverse affect on company, which created a good buying opportunity. As economy re-opens the company will do well. Continues to own the stock.
Photo of Norman LevineNorman Levine
Owned
Unlock Rating
$98.23

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
TOP PICK

EssilorLuxottica(ESLOY)

Sep 30, 2021
Designer, manufacturer, and distributor of lenses, frames, and sunglasses. Market leader. Huge retail presence in Europe and NA. Really strong growth. Strong online presence. Recent acquisition will be transformational. Great story at these levels. Yield is 0.66%.
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
Track your Stocks in your Watch List
TOP PICK

EssilorLuxottica(ESLOY)

Aug 24, 2021
Price target: 169.22 Euros A merger of a French lens company and an Italian frame company, including brands Ray Banz, Chanel, Prada and Oakley, The lens business is stable and amounts to 66% of their revenues. The merger wasn't easy, but he expects $500 million in cut costs. They bought Grand Vision, and its 7,000 European stores to make them a major player in lenses and frames. Now, their online sales are nearly #1 in this space. The only business where they lack are contact lenses. ESLOY is well-integrated, with many of their businesses #1 in their categories. There's a trend of people needing glasses because of looking at TV and computer screens.
Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$95.80

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
TOP PICK

EssilorLuxottica(ESLOY)

Jul 22, 2021

Largest global designer, manufacturer, distributor of lenses in the world. Also does frames and sunglasses. These businesses are resilient and have strong growth going forward. Owns franchises such as LensCrafters and Ray-Ban. GrandVision acquisition will be important. Great balance sheet. Yield is 0.71%.

Photo of Paul Harris, CFAPaul Harris, CFA
Owned
Unlock Rating
$181.27

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
TOP PICK

EssilorLuxottica(ESLOY)

May 07, 2021
Merger of the largest lense maker Essilor with the almost monopolistic maker of eyeware frames Luxotica. Together it is a behemoth. They dominate the market and is also the biggest retailer of eyecare with Pearlvision, LenseCrafters, SunglassHut. Huge in sunglasses too. A return to normal stock. (Analysts’ price target is $179.18)
Photo of Norman LevineNorman Levine
Owned
Unlock Rating
N/A

Stock price when the opinion was issued

$101.92

As of Jun 18, 2026. Market Open.

Healthcare
Showing 1 to 11 of 11 entries
  • «
  • ‹
  • 1
  • ›
  • »

EssilorLuxottica (ESLOY) Frequently Asked Questions

What is EssilorLuxottica stock symbol?

EssilorLuxottica is a American stock, trading under the symbol ESLOY (previously ESLOY-OTC on Stockchase) on the US OTC (ESLOY). It is usually referred to as OTC:ESLOY or ESLOY

Is EssilorLuxottica a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on ESLOY (previously ESLOY-OTC on Stockchase) on Stockchase. Read the latest expert commentary for EssilorLuxottica.

Is EssilorLuxottica a good investment or a top pick?

EssilorLuxottica was recommended as a Top Pick by Norman Levine on 2021-05-07. Read the latest stock experts ratings for EssilorLuxottica.

Why is EssilorLuxottica stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for EssilorLuxottica.

Is EssilorLuxottica worth watching?

EssilorLuxottica is followed by 14 investors on Stockchase and is a trending stock that is worth watching.

What is EssilorLuxottica stock price?

On 2026-06-18, EssilorLuxottica (ESLOY) stock closed at a price of $101.92.

You may also like

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

VEEV 0$153.3
WSP.TO 1.13$176.7
VRTX 0.47$452.1
OTEX.TO 0.24$29.47
CCO.TO 0.61$151.07

Today's Top Picks

NVDA -0.4$210.29
EWJ 0.37$96.63
TECK.B.T… -2.09$88.93
CNQ.TO 0.71$58.66
HHL.TO 0.075$6.865

Popular Articles

Latest Sell Signals

TD.TO 0.7$169.33
MBLY -0.03$8.43
ASAN 0.03$6.95
MODG -0.01$18.21
NVTS 0$24.02

Most Recent Experts

Stockchase Insights

Stockchase Insights

5i Research

Brian Acker, CA

Brian Acker, CA

Acker Finley Inc.

The Weekly Buzzing Stocks by Billy Kawasaki

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

David Burrows

David Burrows

Barometer Capital Management

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: [email protected].

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© 2000 - 2026 Stockchase Inc. by Wealthica